Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Design principles of drug combinations for chemotherapy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Design principles of drug combinations for chemotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Drug Combination
100%
Design Principles
100%
Pegylated Liposomal Doxorubicin
100%
Gemcitabine
71%
Drug Pharmacokinetics
28%
Hill Coefficient
28%
Drug Pair
28%
Drug Interactions
14%
Immune Response
14%
Prodrug
14%
Dose-response
14%
Breast Cancer Treatment
14%
IC50
14%
Liposomes
14%
In Vivo Efficacy
14%
Cancer Treatment
14%
Breast Cancer Model
14%
Doxorubicin
14%
Median Survival Time
14%
Liposomal Encapsulation
14%
M2 Macrophages
14%
Long-term Survival
14%
Highly Aggressive
14%
Combination Chemotherapy
14%
Doxil
14%
Synergistic Drug Combination
14%
Irinotecan
14%
Cancer Drugs
14%
Combination Index
14%
Clinical Option
14%
Drug Action
14%
5-flurouracil
14%
Murine Breast Cancer
14%
Immunogenic Cell Death
14%
Inducing Agents
14%
In Vitro Parameters
14%
Hill Equation
14%
Survival Study
14%
Cellular Assay
14%
Drug Cytotoxicity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Combination Drug
100%
Doxorubicin
100%
Liposome
87%
Gemcitabine
62%
Malignant Neoplasm
25%
Breast Cancer
25%
Pharmacokinetics
25%
Antiinfective Agent
12%
Prodrug
12%
Cancer Model
12%
IC50
12%
Drug Interaction
12%
Median Survival Time
12%
Drug Cytotoxicity
12%
Irinotecan
12%
Long Term Survival
12%
Immunogenic Cell Death
12%